News & Updates
Filter by Specialty:
Pembrolizumab looks good for treated, advanced MSI-H/dMMR endometrial cancer
Use of pembrolizumab helps maintain or improve health-related quality of life in patients with previously treated, advanced endometrial cancer characterized by high levels of microsatellite instability (MSI) or deficient mismatch repair (MSI-H/dMMR), according to data from the phase II KEYNOTE-158 study.
Pembrolizumab looks good for treated, advanced MSI-H/dMMR endometrial cancer
18 Jul 2022
Is laparoscopic better than open partial nephrectomy for renal tumours?
Patients with renal tumours who have undergone laparoscopic partial nephrectomy (LPN) have shown similar surgical and oncologic outcomes as those treated with open partial nephrectomy (OPN), reports a study.
Is laparoscopic better than open partial nephrectomy for renal tumours?
17 Jul 2022
Hospitalization for COVID-19 shorter with dexamethasone vs methylprednisolone
In the treatment of COVID-19 inpatients, intravenous administration of dexamethasone leads to a shorter hospital stay compared with methylprednisolone, according to a study.
Hospitalization for COVID-19 shorter with dexamethasone vs methylprednisolone
17 Jul 2022
Serum CTRP4 tied to coronary artery disease in T2DM
In patients with type 2 diabetes mellitus (T2DM), higher serum levels of circulating C1q tumour necrosis factor-related protein 4 (CTRP4) appear to aggravate the likelihood of coronary artery disease, a recent study has found.